Study looks at effects of low-, high-dose statins on diabetes

04/24/2012 | Medscape (free registration)

Patients who were on high-dose statin treatment did not appear to have a higher risk of developing new-onset diabetes compared with their counterparts who were on low-/moderate-dose statin therapy, an analysis found. Larger prospective studies are needed to examine the risks and benefits of long-term statin use in people at high risk of diabetes, the study's lead author said. The results were presented at the World Congress of Cardiology 2012.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA